EE258 Estimating QALY Gains of Oncology Drugs: A Review of Cost-Utility Analysis of Negotiated Drugs in China
Jul 1, 2022, 00:00 AM
10.1016/j.jval.2022.04.506
https://www.valueinhealthjournal.com/article/S1098-3015(22)00707-0/fulltext
Section Title :
Section Order :
10451
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00707-0&doi=10.1016/j.jval.2022.04.506